Chitnis T, Arnold DL, Banwell B, et al. PARADIGMS: a randomised double-blind study of fingolimod versus interferon β-1a in paediatric multiple sclerosis. ECTRIMS 2017, #276.
Fysieke inactiviteit de grootste modificeerbare risicofactor in de geneeskunde
apr 2024 | Astma